Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MYOV - Regulatory Setback Brings Myovant Sciences Stock To Attractive Levels

MYOV - Regulatory Setback Brings Myovant Sciences Stock To Attractive Levels

Myovant Sciences Ltd.
  • Shares of Myovant Sciences plunged this week after a regulatory setback for Myfembree.
  • No reasons were provided by the FDA yet, and the deficiency letter comes as a big surprise.
  • Orgovyx in advanced prostate cancer remains the key revenue growth driver for the company.
  • Myovant is now trading at attractive levels and can deliver upside even if Myfembree is not approved for the treatment of endometriosis.

For further details see:

Regulatory Setback Brings Myovant Sciences Stock To Attractive Levels
Stock Information
Company Name: Myovant Sciences Ltd.
Stock Symbol: MYOV
Market: NYSE
Website: myovant.com
Menu
MYOV MYOV Quote MYOV Short MYOV News MYOV Articles MYOV Message Board
Get MYOV Alerts

News, Short Squeeze, Breakout and More Instantly...